Varghese Jr., MD, MS, MBA, FACS, chief of general thoracic surgery at the University of Utah in Salt Lake City, offered a more cautious perspective: Its still too early right now, I think, for us to really know what the true incidence rate is around adverse events with GLP-1 receptor agonists. But per current guidelines, it appears limiting GLP-1RA intake before surgery could be unnecessary, easing concerns about balancing efficient surgery with patient safety
Short-term use is rarely effective because the underlying physiological drivers of obesitysuch as hormonal imbalances in appetite regulationoften return once the medication is stopped
The categories most affected by the $3055 billion decline estimated by JPMorgan are precisely those with low nutritional density
PMCID: PMC12409653
For all pair wise comparisons, Risk ratios (RRs) and 95% Confidence Interval (CI) were used as the meta-analytic measure of association between treatment and the incidence of events